Form 4: LifeMD CEO Justin Schreiber Executes Sale of 25,000 Shares Under Pre-Arranged Trading Plan

LifeMD, Inc. Chairman and CEO Justin Schreiber sold 25,000 shares of common stock on July 1, 2025, at a weighted average price of $13.3783, pursuant to a Rule 10b5-1 trading plan.

Summary

• Justin Schreiber, Chairman and CEO of LifeMD, Inc. (LFMD), reported a sale of 25,000 shares of common stock.
• The transaction occurred on July 1, 2025, at a weighted average price of $13.3783 per share.
• The shares were sold in multiple transactions with prices ranging from $13.11 to $13.62.
• The sale was conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating a pre-arranged trading strategy.
• Following the reported transaction, Justin Schreiber's beneficial ownership includes 2,500,721 shares indirectly held by Schreiber Holdings LLC, 200,000 shares held directly, and 13,997 shares indirectly held by each of two children.

Sentiment

Score: 4

Explanation: The sale of shares by a CEO, even under a 10b5-1 plan, can be viewed with slight caution by investors, as it represents a reduction in insider ownership. However, the pre-arranged nature mitigates the negative sentiment compared to an unannounced sale.

Positives

• The transaction was executed under a Rule 10b5-1 plan, which demonstrates adherence to corporate governance best practices by pre-arranging trades to avoid accusations of trading on material non-public information.

Negatives

• The sale of 25,000 shares by the Chairman and CEO could be perceived negatively by investors, as insider selling might suggest a lack of confidence in the company's near-term prospects, despite being part of a pre-arranged plan.

Future Outlook

The document, a Form 4, reports a past insider transaction and does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Justin Schreiber, as the reporting person and Chairman and CEO, executed the sale of 25,000 shares of LifeMD, Inc. common stock.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide information relevant to broader industry trends or competitive landscape analysis. It is specific to LifeMD, Inc. and its executive's stock activity.

Corporate Governance

Related Party Transactions

• Beneficial ownership includes shares held indirectly by Schreiber Holdings LLC and by the reporting person's children, indicating existing related party holdings.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal regarding management's view on future stock performance, potentially leading to increased scrutiny or a negative short-term price reaction, despite the 10b5-1 plan.

Key Dates

Keywords

LifeMD, LFMD, Justin Schreiber, Insider Sale, Form 4, SEC Filing, 10b5-1 Plan, Common Stock, CEO, Chairman